In my country Belgium there was an IPO of a generics Company which was building up market share in 1 country (Belgium) rapidly. Belgium is a small country with about 11 million citizens. Before the IPO at 9 EURO, there was a venture capital capital increase at 2 or 3 EURO 1 year before the IPO. Some days after the IPO at 9 EUR (first trading price 9.11 EUR) there started a real hype about Docpharma, which let the share price double in 1 month. Afterwards the Company Docpharma traded at 35 EUR, with about 2 or 3 million shares outstanding. I believe this points out what we are facing: A HUGE POTENTIAL.